论文部分内容阅读
目的探讨保乳手术治疗乳腺癌Ⅰ期、Ⅱ期患者的临床疗效。方法回顾分析2008年5月至2012年5月我院进行保乳手术治疗的Ⅰ、Ⅱ期乳腺癌患63例的临床资料,分析其手术方法及其疗效。结果所有病例均随访6～48个月(平均27个月)。63例患者中,死亡2例,余无并发症发生。按照Rose采用的乳房美容评定标准进行评价,优36例(57.1%),良好25例(39.7%),差2例(3.2%),总满意率96.8%。结论对I期、Ⅱ期的乳腺癌患者,有保乳手术指征的,尽量行保乳手术治疗,术后进行放疗、化疗治疗和内分泌治疗等综合治疗,不仅可以治疗肿瘤,而且保留了患者身体的完整性,提高了患者的生活质量;保乳手术是治疗Ⅰ期、Ⅱ期乳腺癌比较理想的方法 。
Objective To investigate the clinical efficacy of breast-conserving surgery in stage Ⅰ and stage Ⅱ breast cancer patients. Methods The clinical data of 63 patients with stage Ⅰ and Ⅱ breast cancer undergoing breast-conserving surgery in our hospital from May 2008 to May 2012 were retrospectively analyzed. The surgical methods and their curative effects were analyzed. Results All cases were followed up for 6 ~ 48 months (mean 27 months). Of the 63 patients, 2 died and no complications occurred. Thirty-six (57.1%) were excellent, 25 (39.7%) were good, and two were poor (3.2%), with a total satisfaction rate of 96.8%. Conclusion For stage I and stage II breast cancer patients, breast conserving surgery indications, as far as Paul line breast surgery, postoperative radiotherapy, chemotherapy and endocrine therapy and other comprehensive treatment, not only can treat the tumor, and retain the patient Body integrity, improve the quality of life of patients; breast-conserving surgery is the treatment of stage Ⅰ, Ⅱ breast cancer is the ideal method.